SAG
PFE icon

Spotlight Asset Group’s Pfizer PFE Stock Holding History

Spotlight Asset Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-21,080
Closed -$20K – 153
2020
Q3 		$20K Buy
+21,080
New +$739K 0.01% 145

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Spotlight Asset Group's PFE Position: Q2 2024 in Review

Spotlight Asset Group reduced its Pfizer (PFE) stake by 2.5% in Q2 2024, selling an estimated $4.96K and leaving 6,886 shares worth $193K. The position accounts for 0.13% of the portfolio, ranked #75.

Spotlight Asset Group first reported a position in PFE in Q4 2019 and has held it in 13 quarters since. The position peaked at $381K in Q3 2020. 2,874 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Spotlight Asset Group held 6,886 shares of Pfizer worth $193K as of Q2 2024.
  • Spotlight Asset Group sold 180 Pfizer shares in Q2 2024, an estimated $4.96K.
  • Pfizer made up 0.13% of Spotlight Asset Group's portfolio in Q2 2024, its #75 holding.
  • Spotlight Asset Group first reported a position in Pfizer in Q4 2019 and has held it in 13 quarters since.
  • Spotlight Asset Group's Pfizer position peaked at $381K in Q3 2020.
  • 2,874 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Spotlight Asset Group's 13F filing for Q2 2024, filed 24 Jul 2024.